Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug ...

Seattle-based Talus Bio is going after proteins that resist that approach, notably transcription factors, which control which ...

After more than a year of threats and six months after President Donald Trump signed a national-security proclamation, U.S.

Eli Lilly has agreed to acquire AtaiBeckley for $2.8 billion upfront, plus up to $1 billion in contingent value rights, in a deal that could reach $3.8 billion. The acquisition would make Lilly the ...

The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

The international biotech sector clocked in at $1.37 trillion in 2022 despite headwinds such as slow launches, long-term drug pricing shifts and changing consumer behavior. Recent biotech ...

At its recent annual Science Day, Moderna signalled a strategic expansion beyond its established vaccine and rare disease franchises, unveiling new programs in in vivo CAR-T and solid tumor oncology.

Earendil Labs and NewLimit round out the top three slots in the ranking below, which is limited to private biotechs that announced or disclosed financing between Jan. 1 and Aug. 12, 2026. Earendil ...

As the biotech industry matures, several North American cities are emerging biotech hubs, aiming to become the next epicenters of innovation and growth. While traditional hubs like Boston and San ...

Could the genetic secrets of “extreme mammals” help unlock treatments for myriad human diseases? The Emeryville, California–based startup Fauna Bio is betting on that premise. One of the animals the ...

While San Francisco, Boston, and San Diego may reign as biotech royalty, a new contender is carving its niche in the desert. Las Vegas, a city synonymous with entertainment and extravagance, is ...